Assertio logo

Assertio Share Price Today

(NASDAQ: ASRT)

Assertio share price is $0.82 & ₹71.39 as on 6 Mar 2025, 2.30 'hrs' IST

$0.82

▲

0.05

(6.49%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Assertio share price in Dollar and Rupees. Guide to invest in Assertio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Assertio, along with analyst recommendations, forecasts, and comprehensive financials.

Assertio share price movements

  • Today's Low: $0.77
    Today's High: $0.83

    Day's Volatility :7.22%

  • 52 Weeks Low: $0.73
    52 Weeks High: $1.80

    52 Weeks Volatility :59.27%

Assertio (ASRT) Returns

PeriodAssertio Holdings, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-13.6%
3.7%
0.0%
6 Months
-35.65%
-2.8%
0.0%
1 Year
-8.17%
2.5%
0.0%
3 Years
-64.0%
12.9%
-11.6%

Assertio (ASRT) Key Statistics

in dollars & INR

Previous Close
$0.7675
Open
$0.77
Today's High
$0.8299
Today's Low
$0.77
Market Capitalization
$81.8M
Today's Volume
$384.2K
52 Week High
$1.798
52 Week Low
$0.7324
Revenue TTM
$125.8M
EBITDA
$16.5M
Earnings Per Share (EPS)
$-4.94
Profit Margin
-54.46%
Quarterly Earnings Growth YOY
-0.19%
Return On Equity TTM
-42.36%

How to invest in Assertio Stock (ASRT) from India?

It is very easy for Indian residents to invest directly in Assertio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Assertio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Assertio or ASRT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Assertio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Assertio shares which would translate to 1.062 fractional shares of Assertio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Assertio, in just a few clicks!

Returns in Assertio (ASRT) for Indian investors in Rupees

The Assertio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Assertio investment value today

Current value as on today

₹97,200

Returns

₹2,800

(-2.8%)

Returns from Assertio Stock

₹7,865 (-7.87%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Assertio (ASRT)

264%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Assertio Stock from India on INDmoney has increased by 264% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Assertio

  • Nantahala Capital Management, LLC

    8.53%

  • Vanguard Group Inc

    4.59%

  • Renaissance Technologies Corp

    3.14%

  • BlackRock Inc

    1.47%

  • Millennium Management LLC

    1.15%

  • Geode Capital Management, LLC

    1.15%

Analyst Recommendation on Assertio

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Assertio(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Assertio Stock (ASRT)

What analysts predicted

Upside of 284.15%

Target:

$3.15

Current:

$0.82

Insights on Assertio Stock (Ticker Symbol: ASRT)

  • Price Movement

    In the last 7 days, ASRT stock has moved up by 2.3%

  • Decreasing Revenue

    Revenue is down for the last 8 quarters, 50.35M → 29.20M (in $), with an average decrease of 7.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -279.54M → -2.92M (in $), with an average increase of 402.0% per quarter

  • ASRT vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 98.7% return, outperforming this stock by 106.9%

  • ASRT vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 200.8%

  • Price to Sales

    ForASRT every $1 of sales, investors are willing to pay $0.6, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

ASRT Assertio Financials in INR & Dollars

FY18Y/Y Change
Revenue
$311.8M
↓ 18.11%
Net Income
$36.9M
↓ 136.01%
Net Profit Margin
11.84%
↑ 38.76%
FY19Y/Y Change
Revenue
$229.5M
↓ 26.39%
Net Income
$-217.2M
↓ 688.49%
Net Profit Margin
-94.64%
↓ 106.48%
FY20Y/Y Change
Revenue
$106.3M
↓ 53.69%
Net Income
$-28.1M
↓ 87.04%
Net Profit Margin
-26.48%
↑ 68.16%
FY21Y/Y Change
Revenue
$111.0M
↑ 4.46%
Net Income
$-1.3M
↓ 95.45%
Net Profit Margin
-1.15%
↑ 25.33%
FY22Y/Y Change
Revenue
$156.2M
↑ 40.73%
Net Income
$109.6M
↓ 8657.77%
Net Profit Margin
70.17%
↑ 71.32%
FY23Y/Y Change
Revenue
$152.1M
↓ 2.67%
Net Income
$-331.9M
↓ 402.8%
Net Profit Margin
-218.28%
↓ 288.45%
Q2 FY23Q/Q Change
Revenue
$41.0M
↓ 3.47%
Net Income
$8.5M
↓ 343.11%
Net Profit Margin
20.66%
↑ 28.86%
Q3 FY23Q/Q Change
Revenue
$35.6M
↓ 13.09%
Net Income
$-279.5M
↓ 3400.4%
Net Profit Margin
-784.64%
↓ 805.3%
Q4 FY23Q/Q Change
Revenue
$33.0M
↓ 7.42%
Net Income
$-57.4M
↓ 79.47%
Net Profit Margin
-173.97%
↑ 610.67%
Q1 FY24Q/Q Change
Revenue
$32.4M
↓ 1.63%
Net Income
$-4.5M
↓ 92.14%
Net Profit Margin
-13.9%
↑ 160.07%
Q2 FY24Q/Q Change
Revenue
$31.1M
↓ 4.07%
Net Income
$-3.7M
↓ 18.54%
Net Profit Margin
-11.8%
↑ 2.1%
Q3 FY24Q/Q Change
Revenue
$29.2M
↓ 6.17%
Net Income
$-2.9M
↓ 20.5%
Net Profit Margin
-10.0%
↑ 1.8%
FY18Y/Y Change
Profit
$293.3M
↓ 4.81%
FY19Y/Y Change
Profit
$220.0M
↓ 24.99%
FY20Y/Y Change
Profit
$86.4M
↓ 60.73%
FY21Y/Y Change
Profit
$95.2M
↑ 10.16%
FY22Y/Y Change
Profit
$137.5M
↑ 44.45%
FY23Y/Y Change
Profit
$125.0M
↓ 9.05%
Q2 FY23Q/Q Change
Profit
$36.2M
↓ 2.11%
Q3 FY23Q/Q Change
Profit
$28.6M
↓ 21.13%
Q4 FY23Q/Q Change
Profit
$18.4M
↓ 35.74%
Q1 FY24Q/Q Change
Profit
$15.5M
↓ 15.35%
Q2 FY24Q/Q Change
Profit
$22.2M
↑ 43.1%
Q3 FY24Q/Q Change
Profit
$21.7M
↓ 2.62%
FY18Y/Y Change
Operating Cash Flow
$72.5M
↑ 16.62%
Investing Cash Flow
$-7.1M
↓ 112.23%
Financing Cash Flow
$-81.4M
↓ 26.64%
FY19Y/Y Change
Operating Cash Flow
$90.5M
↑ 24.8%
Investing Cash Flow
$-1.5M
↓ 79.09%
Financing Cash Flow
$-157.8M
↑ 94.02%
FY20Y/Y Change
Operating Cash Flow
$-65.6M
↓ 172.48%
Investing Cash Flow
$512.8M
↓ 34725.32%
Financing Cash Flow
$-468.6M
↑ 196.86%
FY21Y/Y Change
Operating Cash Flow
$5.5M
↓ 108.42%
Investing Cash Flow
$-18.5M
↓ 103.61%
Financing Cash Flow
$29.0M
↓ 106.19%
FY22Y/Y Change
Operating Cash Flow
$78.6M
↑ 1323.1%
Investing Cash Flow
$-42.7M
↑ 130.35%
Financing Cash Flow
$-7.8M
↓ 126.85%
Q2 FY23Q/Q Change
Operating Cash Flow
$18.6M
↓ 18.12%
Investing Cash Flow
$-703.0K
↑ 0.0%
Financing Cash Flow
$-16.3M
↓ 13.85%

Assertio Technicals Summary

Sell

Neutral

Buy

Assertio is currently in a neutral trading position according to technical analysis indicators.

Assertio (ASRT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Assertio Holdings, Inc. logo
Assertio Holdings, Inc.
-0.33%
-35.65%
-8.17%
-64.0%
-80.9%
Intra-cellular Therapies, Inc. logo
Intra-cellular Therapies, Inc.
3.38%
81.15%
98.68%
146.46%
588.66%
Haleon Plc Spon Ads logo
Haleon Plc Spon Ads
10.71%
2.13%
26.53%
42.24%
42.24%
Zoetis Inc. logo
Zoetis Inc.
-3.04%
-10.5%
-9.01%
-11.21%
28.74%
Neurocrine Biosciences Inc. logo
Neurocrine Biosciences Inc.
-25.31%
-6.07%
-13.91%
29.45%
28.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Assertio Holdings, Inc. logo
Assertio Holdings, Inc.
1.2
NA
0.96
-0.18
-0.42
-0.01
NA
1.38
Intra-cellular Therapies, Inc. logo
Intra-cellular Therapies, Inc.
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
Haleon Plc Spon Ads
26.35
26.35
1.92
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
Zoetis Inc.
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
Neurocrine Biosciences Inc.
34.6
34.6
0.27
6.44
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Assertio Holdings, Inc. logo
Assertio Holdings, Inc.
Buy
$81.8M
-80.9%
1.2
-54.46%
Intra-cellular Therapies, Inc. logo
Intra-cellular Therapies, Inc.
Buy
$14.0B
588.66%
NA
-10.97%
Haleon Plc Spon Ads logo
Haleon Plc Spon Ads
Buy
$47.7B
42.24%
26.35
12.84%
Zoetis Inc. logo
Zoetis Inc.
Buy
$76.1B
28.74%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Neurocrine Biosciences Inc.
Buy
$11.4B
28.72%
34.6
14.49%

About Assertio

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Organization
Assertio
Employees
53
CEO
Mr. Brendan P. O'Grady
Industry
Health Technology

Management People of Assertio

NameTitle
Mr. Ajay Patel
Senior VP & CFO
Mr. Paul Schwichtenberg
Chief Transformation Officer
Mr. Brendan P. O'Grady
CEO & Director
Mr. Bill Iskos
Senior Vice President of Operations
Ms. Molly Dir
Senior Vice President of HR & Administration
Mr. Sam Schlessinger
Senior VP & General Counsel
Dr. Howard J. Franklin M.B.A., M.D.
Senior Vice President of Medical
Ms. Mary Pietryga
Chief Commercial Officer

Important FAQs about investing in ASRT Stock from India :

What is Assertio share price today?

Assertio share price today stands at $0.82, Open: $0.77 ; Previous Close: $0.77 ; High: $0.83 ; Low: $0.77 ; 52 Week High: $1.80 ; 52 Week Low: $0.73.

The stock opens at $0.77, after a previous close of $0.77. The stock reached a daily high of $0.83 and a low of $0.77, with a 52-week high of $1.80 and a 52-week low of $0.73.

Can Indians buy Assertio shares?

Yes, Indians can invest in the Assertio (ASRT) from India.

With INDmoney, you can buy Assertio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Assertio at zero transaction cost.

How can I buy Assertio shares from India?

It is very easy to buy Assertio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Assertio (ASRT) be purchased?

Yes, you can buy fractional shares of Assertio with INDmoney app.

What are the documents required to start investing in Assertio stocks?

To start investing in Assertio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Assertio Stock (ASRT)?

Today’s highest price of Assertio (ASRT) is $0.83.

Today’s lowest price of Assertio (ASRT) is $0.77.

What is today's market capitalisation of Assertio?

Today's market capitalisation of Assertio ASRT is 81.8M

What is the 52 Week High and Low Range of Assertio Stock (ASRT)?

  • 52 Week High

    $1.80

  • 52 Week Low

    $0.73

What are the historical returns of Assertio (ASRT)?

  • 1 Month Returns

    -0.33%

  • 3 Months Returns

    -35.65%

  • 1 Year Returns

    -8.17%

  • 5 Years Returns

    -80.9%

Who is the Chief Executive Officer (CEO) of Assertio ?

Mr. Brendan P. O'Grady is the current Chief Executive Officer (CEO) of Assertio.